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One of them, 4"-O-n-butyryl-3"-O-methylleucomycin V, showed improved therapeutic effect in mice.
In search on sixteen-membered macrolides,1) consideration of metabolism at the neutral sugar moiety is one of the key elements to design and generate efficient derivatives. Generally, biological deacylation at the neutral sugar moiety decreases antibacterial activity of ly reported preparations of metabolically stable sixteenmembered macrolide derivatives, 3, 4) which showed enhanced efficiency in vivo.
We set up an alternative strategy for preparation of novel analogues, which we propose metabolically programmed sixteen-membered macrolide derivatives exhibiting excellent activity both in vitro and in vivo. As part of this study, we demonstrated that one of the metabolically programmed derivatives (Scheme 1), 1x
[R=Ac, R1=Et, acyl=COEt], exhibited strong therapeutic effect in mice.5) Improved protective effect of 1x could be mainly explained by its antibiotically active metabolite,6) i. e. 2x [R1=Et] . Since a metabolite (2) having unsubstituted L-cladinose just like of fourteenmembered macrolides is much more active than that having L-mycarose (a diol-type neutral sugar), the parent antibiotic (1) clearly showed improved activity in vivo in comparison with the known acylated sixteen-membered macrolides. Thus, we have extensively investigated chemical modifications of 1 to enhance its antibacterial Scheme 1. Design and biological conversion of metabolically programmed 16-membered macrolide derivatives (1). Three years-analogue study of the leucomycin family (platenomycin skeleton) in our research group have concluded to design metabolically programmed, highly potent derivatives 3, belonging to the leucomycin Fr group (Scheme 2). In this paper, we wish to describe general synthesis of some of the most active derivatives of the leucomycin family and their improved therapeutic effects. We also suggest SAR between a neutral sugar moiety and its antibacterial activity.
Chemistry
To generate metabolically programmed, highly potent leucomycin derivatives (3) we have focused on the followings; (i) screening of an appropriate acyl group at the C-4" position, and (ii) an efficient synthetic method for biological evaluations in vivo. As we have reported in our previous paper,5) the effect of introducing a methyl group at the 3"-hydroxyl group (mycarose to cladinose) may be different depending on the parent structure.
These reasons prompted us to optimize the structure of the acyl group at C-4". Among many possible routes for preparation of 3 (Scheme 2), biotransformations using 1 have been published.6,8) Route A5) starting from natural antibiotics has limitation for designs of the 4"-acyl group, because molecules possessing an unnatural acyl group (for example, n-valeryl) cannot be synthesized efficiently. Even though various kinds of derivatives can be conopted this out. We reasoned that a use of a relatively stable diol 4 to build the 4-O-acyl-L-cladinose moiety would enable us to prepare compounds 3 in a practical scale (route C) for in vivo evaluation. Thus, metabolically programmed, highly potent derivatives (3) were synthesized by utilizing a combination of structurally stable silyl acetal protection10) and methylthiomethyl (MTM) method5) including selective hydrogenolysis of a 3"-MTM ether to a 3"-OMe group.
published method10) to give the acetyl silyl acetal 6 in 83% yield in two steps (Scheme 3). Upon carefully controled, heterogeneous basic hydrolysis of 6 afforded a diol (4) Direct methylation at the 3"-hydroxyl group in 7
possessing a cis-vicinal acyloxy group led to complicated results. Also the same reaction conditions using model compounds 11a4) and 11e which were rather stable at C-2' (Fig. 1) , showed messy spots in TLC Thus, after careful study the MTM method was finally adopted to construct the 3"-OMe group. Practical methylthiomethlow yields. The 3"-hydroxyl group in 7 seems to be highly hindered sterically in addition to its low reactivity12). We reasoned that the substrates 11a and 11e might change their molecular conformation by introducing a large substituent in the C-2' position, and thus might relieve steric factors. Although the yield could not be improved using the 2'-silyl derivatives (11a and 11e), methylthiomethylation of 7 was accomplished by addition of benzoic anhydride13) to afford 8 in moderate yield. methyl group14) by selective hydrogenolysis using de- gestions (vide supra), we used an alternative MTM intermediate 12 ( Fig. 1 ) to overcome this steric hindrance, but the yields was not improved. Previously, we have reported5), the reduction of an MTM ether to a methoxy group was influenced by the substituent at the C-9 position. Hydrogenolysis of 9-O-acetyl substrate (13) correctly introduced at C-3". Moreover, the same acidic solvolysis of 3e and 1y [R=H, R1=Me, acyl= COCH2CH(CH3)2]5) (Scheme 1) prepared from josamycin, directly gave an identical product, ethyl 4-O-ivaleryl-L-cladinoside. These results suggested that the chemical acylation of 4 to 7 (Scheme 3) took place at the C-4" position correctly without any acyl migrations. To design a more convergent synthetic scheme, an attempt was made to remove the 4"-O-propionyl group at the later stage, but efficient deacylation at the C-4" position was not feasible at the stage of compounds 8, 9 or 10. These results could be explained by not only steric hindrance of the 3"-substituent but intramolecular effects of the free hydroxyl group at C-3" for 4"-deacylation also.
Regioselective acylation of 3b with acyl chloride in toluene gave 9-O-acetyl derivative (14) and 9-O-propionate (15) (Fig. 2) . Minimum inhibitory concentrations (MICs) were determined by the agar dilution method. Test strains were subjected to seed culture using Sensitivity test broth (STB, Nissui Pharmaceutical) except the strains belonging to the genus Streptococcus, Moraxella and Haemophilus which were cultured on blood agar plate.
about 106CFU/ml was inoculated into Sensitivity disk agar (SDA, Nissui Pharmaceutical) supplemented with 5% horse blood in cases of Streptococcus, Moraxella and
To 10.0g (13.2 mmol) of leucomycin A7 (LM-A7) was added dry CH3CN (200ml), and 2.50ml (26.4 mmol) of acetic anhydride (Ac2O) was added. The mixture was stirred at room temperature for 16 hours. After slowly adding saturated aqueous NaHCO3 (500ml), the reaction mixture was extracted with CH2Cl2 (500ml). Then organic layer was dried and concentrated to afford crude 5 (10.55g, quant.). To 10.55g of 5 was added dry DMF (100ml), and 5.97g (39.6 mmol) of t-butyldimethylsilyl chloride (TBSCI) and 5.39g (79.2 mmol) of imidazole
The reaction mixture was extracted with benzene (1 liter) and the benzene layer was successively washed with saturated aqueous NaHCO3 (1 liter) twice and brine (1 liter) twice. Then the organic layer was dried and concentrated to afford 13.2g of crude 6. A 50mg portion of this crude compound was purified by preparative TLC [hexane-AcOEt (5:1)] to afford 6 (42mg, 83%) as a colorless solid. 2'-O-Acetyl-9, 18-di-O-tert-butyldimethylsilylleucomycin V 3,18-Acetal (4) 334ml of benzene was added to 6.68g (6.5 mmol) of 6, and 25% aqueous NaOH (167ml) and 2.19g (6.45 mmol) of tetra-n-butylammonium hydrogensulfate were benzene layer was collected and washed with brine 
To a stirred mixture of 4 (500mg, 0.52 mmol) in pyridine (5.0ml) was added butyrylchloride (66mg, 0.62 mmol). The resulting mixture was stirred at room temperature for 15 minutes. After slowly adding saturated aqueous NaHCO3 (500ml), the reaction mixture was extracted with CHCl3 (250ml) twice. The organic layers were combined, washed with brine (500ml) 9-O-Acetyl-18-O-tert-butyldimethylsilyl-3"-O-methylthiomethylleucomycin A7 3, 18-Acetal (13) To 5.00g (6.60mmol) of LM-A7 was added dry pyridine (100ml), and 2.70g (37.8mmol) of Ac2O was added. The mixture was stirred at room temperature for 2 days. After slowly adding saturated aqueous NaHCO3 (500ml), the reaction mixture was extracted with CH2Cl2 (500ml). Then organic layer was dried and the resulting residue was purified by silica gel column chromatography [300g, hexane-AcOEt (1:3)]. Thus, 3.30g (60%) of 9,"-di-O-acetylleucomycin A7 was obtained. To 3.05g 
